US2021071239A1PendingUtilityA1

Methods for determining base locations in a polynucleotide

Assignee: UNIV CALIFORNIAPriority: Apr 6, 2015Filed: Jul 22, 2020Published: Mar 11, 2021
Est. expiryApr 6, 2035(~8.7 yrs left)· nominal 20-yr term from priority
C12Q 1/6869C12Q 1/6827C12Q 2521/531C12Q 2525/119C12Q 2565/631C12Q 2537/164C12Q 2563/116
57
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Disclosed are methods for polynucleotide sequencing that detect the location of selected nucleobases with greater precision. The methods can be used to determine the location and nature of modified bases in a polynucleotide, that is, non-canonical bases, or to improve accuracy of sequencing of “problem” regions of DNA sequencing such as homopolymers, GC rich areas, etc. The sequencing method exemplified is nanopore sequencing. Nanopore sequencing is used to generate a unique signal at a point in a polynucleotide sequence where an abasic site (AP site, or apurinic or apyrimidinic site) exists. As part of the method, an abasic site is specifically created enzymatically using a DNA glycosylase that recognizes a pre-determined nucleobase species and cleaves the N-glycosidic bond to release only that base, leaving an AP site in its place.

Claims

exact text as granted — not AI-modified
1 - 28 . (canceled) 
     
     
         29 . A method of detecting a sequence in an RNA polynucleotide molecule, the method comprising:
 (a) treating the RNA polynucleotide molecule with an RNA glycosylase that creates an abasic site corresponding to pseudouridine (Ψ), diydrouridine (D), inosine (I), and 7-methylguanosine (m7g) species in the polynucleotide;   (b) conducting single molecule sequencing on the polynucleotide prepared in step (a) where the sequencing indicates the abasic site within the polynucleotide sequence; and   (c) using the sequence from step (b) to identify the abasic site and correlating said abasic site to pseudouridine ('P), diydrouridine (D), inosine (I), and 7-methylguanosine (m7g).   
     
     
         30 . The method of  claim 29 , wherein the RNA glycosylase is EC 3.2.2.22. 
     
     
         31 . The method of  claim 29 , wherein the RNA glycosylase lacks beta lyase activity. 
     
     
         32 . The method of  claim 31 , wherein the RNA glycosylase is engineered to lack beta lyase activity. 
     
     
         33 . The method of  claim 29 , wherein conducting single molecule sequencing comprises nanopore-based sequencing comprises measuring an ionic current that identifies an abasic site. 
     
     
         34 . The method of  claim 33 , wherein the nanopore-based sequencing includes detecting an ionic current through a nanopore through which the polynucleotide passes. 
     
     
         35 . The method of  claim 31 , wherein conducting single molecule sequencing comprises nanopore-based sequencing comprises measuring an ionic current that identifies an abasic site. 
     
     
         36 . The method of  claim 35 , wherein the nanopore-based sequencing includes detecting an ionic current through a nanopore through which the polynucleotide passes. 
     
     
         37 . The method of  claim 29 , wherein the RNA polynucleotide molecule is mRNA. 
     
     
         38 . The method of  claim 29 , wherein the RNA polynucleotide molecule is tRNA. 
     
     
         39 . The method of  claim 29 , wherein the RNA polynucleotide molecule is genomic RNA.

Join the waitlist — get patent alerts

Track US2021071239A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.